Disitamab Vedotin in HER2-Positive and HER2-Low Breast Cancer: A Multicenter Retrospective Analysis
Disitamab Vedotin治疗HER2阳性及HER2低表达乳腺癌:一项多中心回顾性分析
期刊:Oncology Research
影响因子:4.1
doi:10.32604/or.2025.065029
Zhang, Xizhou; Zhang, Zetao; Lin, Jianguang; Yi, Jiarong; Zou, Xuxiazi; Feng, Jikun; Huang, Guangsheng; Chen, Bingfeng; Long, Junxi; Wu, Fengjia; Ye, Feng; Wu, Haoming